Epidemiological characteristics and genomic analysis of respiratory adenovirus in Lanzhou City from 2023 to 2025
The prevalent HAdV strain in Lanzhou City from 2023 to 2025 was type B3. Based on these findings, it is tentatively suggested that the vaccine candidate strain from Guangzhou may provide good immune protection against these prevalent strains, though verification through clinical trials is required.
Authors
- H Y Zhang
- Shu Liang
- Miao Wang (ORCID: https://orcid.org/0000-0003-4892-6139)
- Biao Wang
- Xiaoshu Zhang
- Maoxing Dong
- Huan Wei
Institutions
- Gansu University of Traditional Chinese Medicine (CN)
- Gansu Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3389/fcimb.2025.1680735
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00